Synergistic Inhibition of Nav1.7 and NCX 1: A Novel Strategy for Treating Cancer‐Induced Bone Pain by Modulating Pain Sensitization and Neuronal Inflammation
CNS Neuroscience & Therapeutics · 2025-04 · 31 (4)
DOI: 10.1111/cns.70389 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 18.04.2025. Verfasst von Yan Feng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen …. Hauptthemen laut MEDLINE: Sodium-Calcium Exchanger, NAV1.7 Voltage-Gated Sodium Channel, Cancer Pain, Bone Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
Aims
Cancer‐induced bone pain (CIBP) is a chronic and refractory pain condition characterized by neuronal hyperexcitability, calcium dysregulation, and neuroinflammation. Voltage‐gated sodium channels (VGSCs) and sodium/calcium exchangers (NCXs) are crucial in regulating sensory neuron sodium–calcium homeostasis, influencing nociceptive signaling and neuroinflammatory responses. This study focused on exploring how Nav1.7 from the VGSC family and NCX1 from the NCX family influence nociceptive signaling and neuroinflammation in CIBP.
Methods
CIBP was induced in mice. Nav1.7 and NCX1 expression and colocalization in DRG neurons were analyzed by qPCR, western blotting, and immunofluorescence. Calcium overload and neuronal excitability were assessed using calcium imaging and electrophysiological recordings. Neuroinflammation markers were detected by qPCR and western blotting.
Results
Among the VGSC and NCX subtypes, Nav1.7 and NCX1 were notably upregulated and colocalized in the DRG neurons of CIBP mice. Combined inhibition of these channels demonstrated a synergistic analgesic effect and markedly reduced neuronal calcium overload and hyperexcitability. Furthermore, the combined inhibition substantially alleviated neuroinflammation by inhibiting the p38 MAPK/NF‐κB pathway and lowering proinflammatory cytokine levels.
Conclusions
The combined inhibition of Nav1.7 and NCX1 enhances analgesic effects and reduces neuroinflammation, presenting a potential therapeutic approach for CIBP and other cancer‐associated pain disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.
- Department of Anesthesiology, Huizhou Municipal Central Hospital, Huizhou, China.
- Department of Anesthesiology, Guangdong Women and Children Hospital, Guangzhou, China.
ORCID-Profile: Yan Feng, Dongtai Chen, Yang Huang
Förderung
- National Natural Science Foundation of China
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Feng, Y., Yan, F., Chen, D., Wang, P., Yan, Y., Chen, X., Li, Q., Xing, W., Zeng, W., & Huang, Y. (2025). Synergistic Inhibition of Nav1.7 and NCX 1: A Novel Strategy for Treating Cancer‐Induced Bone Pain by Modulating Pain Sensitization and Neuronal Inflammation. CNS Neuroscience & Therapeutics, 31(4). https://doi.org/10.1111/cns.70389
Vancouver
Feng Y, Yan F, Chen D, Wang P, Yan Y, Chen X, et al. Synergistic Inhibition of Nav1.7 and NCX 1: A Novel Strategy for Treating Cancer‐Induced Bone Pain by Modulating Pain Sensitization and Neuronal Inflammation. CNS Neuroscience & Therapeutics. 2025;31(4). doi:10.1111/cns.70389
BibTeX
@article{Feng2025,
author = {Feng, Yan and Yan, Fang and Chen, Dongtai and Wang, Peizong and Yan, Yan and Chen, Xiangnan and Li, Qiang and Xing, Wei and Zeng, Weian and Huang, Yang},
title = {Synergistic Inhibition of Nav1.7 and NCX 1: A Novel Strategy for Treating Cancer‐Induced Bone Pain by Modulating Pain Sensitization and Neuronal Inflammation},
journal = {CNS Neuroscience & Therapeutics},
year = {2025},
volume = {31},
number = {4},
doi = {10.1111/cns.70389}
}
EUVIMED